🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Treatment Acquiring Traction Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to contact these accounts privately for supplier links, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust market exists on messaging services, where groups with numerous of members share “before and after” images, injection guides and assertions of next-day British shipping. Sellers market the drug there before redirecting customers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could result in users injecting substances of unknown origin.

Some professionals said the demand for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, risking fines, legal action or imprisonment.

Platform Reaction and Material Removal

According to the social media company, the service has removed problematic material and banned associated keywords and query recommendations. The organization said it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.

Online Marketplace Activities

Research also discovered groups with up to 9,000 members selling the experimental drug using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, filled with photos of weight loss, positive testimonials and detailed guides for mixing or injecting at home.

After minutes of entering one community, a vendor shared WhatsApp details, where the majority of transactions occur. The vendor provided an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Product Information and Pricing

Inside these groups, posts show black plastic parcels with Royal Mail labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or pre-filled pens usually priced at £160 for 20 milligrams. When asked how much time a pen should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for Telegram stated it regularly moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting materials they cannot confirm. Although the research behind this drug is sound, these online products may not contain what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to recent cost increases for approved slimming medications such as Mounjaro. “With costs rising, individuals are turning to social media. But fake injections are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.

Her team has already seen individuals harmed by self-injection from unverified sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company investigational product not yet authorized … may subject users to possibly serious health risks”.